Table 4 Univariate Cox regression analysis for overall survival
From: Quality of life assessment as a predictor of survival in non-small cell lung cancer
QoL Domain | HR | 95% CI | P-value |
|---|---|---|---|
Global | 0.991 | 0.989 to 0.994 | < 0.001 |
Physical | 0.988 | 0.985 to 0.990 | < 0.001 |
Role | 0.993 | 0.991 to 0.995 | < 0.001 |
Emotional | 0.997 | 0.994 to 1.00 | 0.04 |
Cognitive | 0.996 | 0.993 to 0.999 | 0.003 |
Social | 0.994 | 0.992 to 0.996 | < 0.001 |
Fatigue | 1.009 | 1.006 to 1.011 | < 0.001 |
Nausea/vomiting | 1.005 | 1.002 to 1.008 | 0.001 |
Pain | 1.006 | 1.004 to 1.009 | < 0.001 |
Dyspnea | 1.005 | 1.003 to 1.008 | < 0.001 |
Insomnia | 1.000 | 0.998 to 1.003 | 0.66 |
Appetite Loss | 1.006 | 1.004 to 1.008 | < 0.001 |
Constipation | 1.004 | 1.002 to 1.006 | 0.001 |
Diarrhea | 1.004 | 1.001 to 1.008 | 0.02 |
Age at presentation | 0.998 | 0.991 to 1.006 | 0.65 |
Gender (male as reference) | 0.77 | 0.67 to 0.89 | < 0.001 |
Stage at diagnosis (locoregional disease as reference) | 1.57 | 1.4 to 1.8 | < 0.001 |
Prior treatment history (previously treated as reference) | 0.55 | 0.48 to 0.64 | < 0.001 |